Arrowstreet Capital, Limited Partnership Corcept Therapeutics Inc Transaction History

Arrowstreet Capital, Limited Partnership

$122 Billion
Q4 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,644,942 shares of CORT stock, worth $105 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,644,942

Previous 1,580,621 4.07%

Holding current value

$105 Million

Previous $73.1 Million 13.36%

% of portfolio

0.07%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$44.66 - $60.85 $2.87 Million - $3.91 Million	64,321 Added 4.07%	1,644,942 $82.9 Million
Q3 2024 Nov 14, 2024	BUY	$29.51 - $46.26 $2.87 Million - $4.5 Million	97,199 Added 6.55%	1,580,621 $73.1 Million
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $4.51 Million - $7.01 Million	-203,249 Reduced 12.05%	1,483,422 $48.2 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $12.4 Million - $16.1 Million	585,568 Added 53.18%	1,686,671 $42.5 Million
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $108,364 - $143,554	-4,366 Reduced 0.39%	1,101,103 $35.8 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $18.1 Million - $27.8 Million	822,279 Added 290.36%	1,105,469 $30.1 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $5.86 Million - $6.87 Million	273,097 Added 2705.81%	283,190 $6.3 Million
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $248,736 - $317,008	-12,955 Reduced 56.21%	10,093 $219,000
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $459,807 - $690,518	23,048 New	23,048 $468,000
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $245,080 - $357,792	-14,142 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$16.53 - $25.21 $7.89 Million - $12 Million	-477,020 Reduced 97.12%	14,142 $318,000
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $17.1 Million - $23.3 Million	-998,382 Reduced 67.03%	491,162 $9.73 Million
Q3 2021 Nov 12, 2021	BUY	$19.68 - $22.53 $16.8 Million - $19.2 Million	853,576 Added 134.22%	1,489,544 $29.3 Million
Q2 2021 Aug 13, 2021	SELL	$19.97 - $24.43 $8.21 Million - $10 Million	-411,295 Reduced 39.27%	635,968 $14 Million
Q1 2021 May 14, 2021	BUY	$23.49 - $30.56 $547,951 - $712,873	23,327 Added 2.28%	1,047,263 $24.9 Million
Q4 2020 Feb 12, 2021	BUY	$16.78 - $27.3 $1.42 Million - $2.31 Million	84,528 Added 9.0%	1,023,936 $26.8 Million
Q3 2020 Nov 12, 2020	BUY	$12.46 - $19.98 $105,349 - $168,930	8,455 Added 0.91%	939,408 $16.4 Million
Q2 2020 Aug 12, 2020	SELL	$11.0 - $18.26 $2.8 Million - $4.65 Million	-254,784 Reduced 21.49%	930,953 $15.7 Million
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $2.29 Million - $3.19 Million	-226,890 Reduced 16.06%	1,185,737 $14.1 Million
Q4 2019 Feb 13, 2020	BUY	$12.06 - $16.96 $17 Million - $24 Million	1,412,627 New	1,412,627 $17.1 Million
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $3.07 Million - $4.01 Million	-314,400 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $919,249 - $1.44 Million	91,650 Added 41.14%	314,400 $3.69 Million
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $2.51 Million - $3.83 Million	222,750 New	222,750 $2.98 Million
Q3 2018 Nov 14, 2018	SELL	$12.27 - $15.65 $10.4 Million - $13.3 Million	-849,978 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$15.3 - $19.69 $209,579 - $269,713	13,698 Added 1.64%	849,978 $13.4 Million
Q1 2018 May 14, 2018	BUY	$14.59 - $25.5 $4.3 Million - $7.52 Million	294,834 Added 54.45%	836,280 $13.8 Million
Q4 2017 Feb 09, 2018	SELL	$15.77 - $20.72 $1.31 Million - $1.72 Million	-82,829 Reduced 13.27%	541,446 $9.78 Million
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $7.68 Million - $12 Million	624,275	624,275 $12 Million

Others Institutions Holding CORT

# of Institutions

403

Shares Held

84.3M

Call Options Held

1.04M

Put Options Held

1.33M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.81B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Corcept Therapeutics Inc Transaction History